180 related articles for article (PubMed ID: 10679914)
1. Genetic and phenotypic changes associated with the acquisition of tumorigenicity in human bladder cancer.
Gildea JJ; Golden WL; Harding MA; Theodorescu D
Genes Chromosomes Cancer; 2000 Mar; 27(3):252-63. PubMed ID: 10679914
[TBL] [Abstract][Full Text] [Related]
2. The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines.
Seraj MJ; Harding MA; Gildea JJ; Welch DR; Theodorescu D
Clin Exp Metastasis; 2000; 18(6):519-25. PubMed ID: 11592309
[TBL] [Abstract][Full Text] [Related]
3. Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia.
Wu Y; McRoberts K; Berr SS; Frierson HF; Conaway M; Theodorescu D
Oncogene; 2007 Feb; 26(5):765-73. PubMed ID: 16878152
[TBL] [Abstract][Full Text] [Related]
4. T24 HRAS transformed NIH/3T3 mouse cells (GhrasT-NIH/3T3) in serial tumorigenic in vitro/in vivo passages give rise to increasingly aggressive tumorigenic cell lines T1-A and T2-A and metastatic cell lines T3-HA and T4-PA.
Ray DB; Merrill GA; Brenner FJ; Lytle LS; Lam T; McElhinney A; Anders J; Rock TT; Lyker JK; Barcus S; Leslie KH; Kramer JM; Rubenstein EM; Pryor Schanz K; Parkhurst AJ; Peck M; Good K; Granath KL; Cifra N; Detweiler JW; Stevens L; Albertson R; Deir R; Stewart E; Wingard K; Richardson MR; Blizard SB; Gillespie LE; Kriley CE; Rzewnicki DI; Jones DH
Exp Cell Res; 2016 Jan; 340(1):1-11. PubMed ID: 26254261
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of normal and mutated forms of HRAS induces orthotopic bladder invasion in a human transitional cell carcinoma.
Theodorescu D; Cornil I; Fernandez BJ; Kerbel RS
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):9047-51. PubMed ID: 2247480
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice.
Dinney CP; Fishbeck R; Singh RK; Eve B; Pathak S; Brown N; Xie B; Fan D; Bucana CD; Fidler IJ
J Urol; 1995 Oct; 154(4):1532-8. PubMed ID: 7658585
[TBL] [Abstract][Full Text] [Related]
7. Divergent behaviors and underlying mechanisms of cell migration and invasion in non-metastatic T24 and its metastatic derivative T24T bladder cancer cell lines.
Jin H; Yu Y; Hu Y; Lu C; Li J; Gu J; Zhang L; Huang H; Zhang D; Wu XR; Gao J; Huang C
Oncotarget; 2015 Jan; 6(1):522-36. PubMed ID: 25402510
[TBL] [Abstract][Full Text] [Related]
8. Functional genomic comparison of lineage-related human bladder cancer cell lines with differing tumorigenic and metastatic potentials by spectral karyotyping, comparative genomic hybridization, and a novel method of positional expression profiling.
Harding MA; Arden KC; Gildea JW; Gildea JJ; Perlman EJ; Viars C; Theodorescu D
Cancer Res; 2002 Dec; 62(23):6981-9. PubMed ID: 12460916
[TBL] [Abstract][Full Text] [Related]
9. Influence of the microenvironment on invasiveness of human bladder carcinoma cell lines.
Bindels EM; Vermey M; De Both NJ; van der Kwast TH
Virchows Arch; 2001 Oct; 439(4):552-9. PubMed ID: 11710643
[TBL] [Abstract][Full Text] [Related]
10. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.
Dhawan D; Ramos-Vara JA; Stewart JC; Zheng R; Knapp DW
Urol Oncol; 2009; 27(3):284-92. PubMed ID: 18562222
[TBL] [Abstract][Full Text] [Related]
11. T24 human bladder carcinoma cells with activated Ha-ras protooncogene: nontumorigenic cells susceptible to malignant transformation with carcinogen.
Senger DR; Perruzzi CA; Ali IU
Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5107-11. PubMed ID: 3293049
[TBL] [Abstract][Full Text] [Related]
12. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
Kunze E; Wendt M; Schlott T
Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
[TBL] [Abstract][Full Text] [Related]
13. [Loss of heterozygosity of tumor suppressor genes at chromosome 3p in transitional cell carcinoma of urinary bladder].
Xiao Z; Zhang J; Zheng S; Li C; He Z; Cheng S; Gao Y
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1375-7. PubMed ID: 12509916
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal characterization and isoenzyme pattern of non-malignant and malignant human urothelial cell lines.
Debiec-Rychter M; Christensen B; Kieler J; Wang CY
Anticancer Res; 1986; 6(5):1237-44. PubMed ID: 3800330
[TBL] [Abstract][Full Text] [Related]
15. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
[TBL] [Abstract][Full Text] [Related]
16. Identification of cytogenetic subgroups and karyotypic pathways in transitional cell carcinoma.
Höglund M; Säll T; Heim S; Mitelman F; Mandahl N; Fadl-Elmula I
Cancer Res; 2001 Nov; 61(22):8241-6. PubMed ID: 11719456
[TBL] [Abstract][Full Text] [Related]
17. Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model.
Grippo PJ; Sandgren EP
Am J Pathol; 2000 Sep; 157(3):805-13. PubMed ID: 10980120
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a newly established human urinary bladder cancer cell line (BT-1).
Heckl W; Köhler J; Hoehn H; Dämmrich J
Urol Res; 1988; 16(1):23-9. PubMed ID: 3344562
[TBL] [Abstract][Full Text] [Related]
19. Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder.
Chaffer CL; Dopheide B; McCulloch DR; Lee AB; Moseley JM; Thompson EW; Williams ED
Clin Exp Metastasis; 2005; 22(2):115-25. PubMed ID: 16086232
[TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of two human bladder cancer cell lines.
Naito S; Kotoh S; Koga H; Hasegawa S; Yamasaki T; Noma H; Kumazawa J
Hum Cell; 1996 Mar; 9(1):49-56. PubMed ID: 9183630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
